Researchers are hopeful that this 'ground-breaking approach' could accelerate the prediction of which patients are more at risk of their disease returningOriginal Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.